Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-12-20

Clinical Trial Update: Effect of Febuxostat Compared to Placebo on Exercise Tolerance in Participants With Chronic Stable Angina [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing febuxostat to placebo assessed exercise tolerance in participants with chronic stable angina; the study was terminated and results wer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Febuxostat (Uloric) (febuxostat)

Snippet

Sponsor: Takeda | Conditions: Angina | Phase 2 | Status: TERMINATED | Results posted: 2013-12-20